ATG5 and malignant glioma: Rapamycin, an inhibitor of the mTOR signaling pathway, promoted malignant glioma cell death and sensitized glioma to combined radiotherapy or temozolomide treatment by autophagic activation along with increased expression of Beclin-1, Atg5 and LC3-II45.